Geode Capital Management, LLC Second Sight Medical Products Inc Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.22 - $2.57 $46,639 - $98,248	38,229 Added 17.53%	256,322 $520,000
Q1 2022 May 13, 2022	BUY	$1.16 - $1.83 $49,074 - $77,419	42,306 Added 24.07%	218,093 $311,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $3.41 $51,524 - $107,790	31,610 Added 21.92%	175,787 $286,000
Q3 2021 Nov 12, 2021	SELL	$3.11 - $4.75 $7,308 - $11,162	-2,350 Reduced 1.6%	144,177 $459,000
Q2 2021 Aug 13, 2021	BUY	$4.94 - $9.43 $193,405 - $369,193	39,151 Added 36.46%	146,527 $723,000
Q1 2021 May 12, 2021	BUY	$1.43 - $15.48 $50,238 - $543,843	35,132 Added 48.63%	107,376 $885,000
Q4 2020 Feb 12, 2021	BUY	$0.73 - $3.22 $31,247 - $137,832	42,805 Added 145.4%	72,244 $135,000
Q1 2020 May 14, 2020	BUY	$1.0 - $6.05 $29,439 - $178,105	29,439 New	29,439 $29,000

Ticker EYES
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,136,400
Market Cap $54.4M
Description
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.